US 12,070,449 · Application 17/332,359 · Granted Aug 27, 2024
US 12,070,449
Methods of treating ttr amyloidosis using ag10
Estimated expiration
March 22, 2039
12y 188d remaining
Earliest effective filing
Mar 22, 2019
+ 20 years
Mar 22, 2039
PTA +31d
Apr 22, 2039
TD cap (US 11,058,668)
Mar 22, 2039
Final
Mar 22, 2039
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- May 27, 2021
- Earliest effective filing
- March 22, 2019
- Issue date
- August 27, 2024
- PTA
- +31 days
- Base expiry (before PTA)
- March 22, 2039
March 22, 2019 + 20 years = March 22, 2039 + 31 PTA days = April 22, 2039
- Continuation of application 16/361,587, filed Mar 22, 2019, issued as US 11,058,668
- PRO62/647,411 — Provisional — not used for base term
- PRO62/765,096 — Provisional — not used for base term
- PRO62/731,629 — Provisional — not used for base term
- PRO62/758,235 — Provisional — not used for base term
- PRO62/810,651 — Provisional — not used for base term
- PRO62/647,411 — Provisional — not used for base term
- PRO62/765,096 — Provisional — not used for base term
- PRO62/731,629 — Provisional — not used for base term
- PRO62/758,235 — Provisional — not used for base term
- PRO62/810,651 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to March 22, 2039 (earliest expiring referenced patent: US 11,058,668)
US 11,058,668· Application 16/361,587Capping patent
Methods of treating ttr amyloidosis using ag10
- Filing date
- Mar 22, 2019
- Earliest effective filing
- Mar 22, 2019
- Issue date
- Jul 13, 2021
- PTA
- 0 days
- Calculated expiration
- Mar 22, 2039
Mar 22, 2019 + 20y = Mar 22, 2039
US 12,070,449· Application 17/332,359(from application 17/332,359)
Methods of treating ttr amyloidosis using ag10
- Filing date
- May 27, 2021
- Earliest effective filing
- Mar 22, 2019
- Issue date
- Aug 27, 2024
- PTA
- +31 days
- Calculated expiration
- Apr 22, 2039
Continuation of 16/361,587, filed Mar 22, 2019, issued as US 11,058,668
Mar 22, 2019 + 20y + 31d PTA = Apr 22, 2039
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/332,359 · US 12,070,449
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,070,449: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12070449Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.